Antal Rohit Desai sold $4.7M of PROCEPT BioRobotics (PRCT)

Executed Jun 10 2025, disclosed Jun 12 2025, 2 days later.

Value, as filed

$4.7M

75,000 sh across 8 lots

Executed

Jun 10 2025

the trade date, as filed

Disclosed

Jun 12 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AD Antal Rohit Desai Director profile →

Antal Rohit Desai (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in PROCEPT BioRobotics Corporation (PRCT). Across 1 priced purchase filing, the average 21-session return was -4.6% from execution and -2.6% from disclosure (delay-adjusted; derived). The largest single filing was $10.4M of PRCT (424,962 sh across 6 lots, as filed), executed Mar 5.

The name

PRCT PROCEPT BioRobotics Corporation PRCT · Healthcare · 21 filings in 24 months ticker →

Healthcare · PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and interna…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Antal Rohit Desai in PRCT

PRCTPURCHASE PROCEPT BioRobotics Corporation $10.4M
424,962 sh across 6 lots
Exec Mar 5
Filed Mar 9 · 7:19 PM ET PRCTSALE PROCEPT BioRobotics Corporation $4.4M
70,682 sh across 8 lots
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET PRCTSALE PROCEPT BioRobotics Corporation $9.6M
99,500 sh across 11 lots
Exec Nov 5 2024
Filed Nov 7 2024 · 5:30 PM ET PRCTSALE PROCEPT BioRobotics Corporation $9.4M
120,065 sh across 10 lots
Exec Sep 10 2024
Filed Sep 12 2024 · 5:30 PM ET